Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of ACC017 versus dolutegravir in treatment-naive adults with HIV-1 infection
CTR20253999Phase 3Active
- Sponsor
- Aidi Pharma
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of asuptegravir in Human immunodeficiency virus infection type 1, sponsored by Aidi Pharma. Started Nov 2025; status: active.
02
Drugs
asuptegravir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on CTR20253999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253999.